Published in Am J Psychiatry on July 01, 1982
Comparing the efficacy of medications for ADHD using meta-analysis. MedGenMed (2006) 1.51
Using Meta-analysis to Compare the Efficacy of Medications for Attention-Deficit/Hyperactivity Disorder in Youths. P T (2009) 1.36
The psychopathic personality in a longitudinal perspective. Eur Child Adolesc Psychiatry (1996) 0.75
Automated microbiological detection/identification system. J Clin Microbiol (1977) 16.88
Suppression of subclinical shedding of herpes simplex virus type 2 with acyclovir. Ann Intern Med (1996) 3.35
An inherited limb deformity created by insertional mutagenesis in a transgenic mouse. Nature (1985) 3.05
International Union of Pharmacology. X. Recommendation for nomenclature of alpha 1-adrenoceptors: consensus update. Pharmacol Rev (1995) 2.53
Subtypes of alpha 2-adrenoceptors: pharmacological and molecular biological evidence converge. Trends Pharmacol Sci (1988) 2.27
Heterogeneity of alpha-2 adrenergic receptors. Pharmacol Biochem Behav (1985) 1.84
Long-term acyclovir suppression of frequently recurring genital herpes simplex virus infection. A multicenter double-blind trial. JAMA (1988) 1.76
Beta adrenergic receptor binding in membrane preparations from mammalian brain. Mol Pharmacol (1976) 1.72
Substrate specificity of the cyclic AMP-dependent protein kinase. Proc Natl Acad Sci U S A (1975) 1.68
Expression of beta-amyloid precursor protein in reactive astrocytes following neuronal damage. Neuron (1989) 1.59
The amino acid sequences of the phosphorylated sites in troponin-I from rabbit skeletal muscle. FEBS Lett (1974) 1.49
Double-blind controlled trial of topical acyclovir in genital herpes simplex virus infections. Am J Med (1982) 1.42
Combination therapy with zidovudine and didanosine compared with zidovudine alone in HIV-1 infection. Ann Intern Med (1993) 1.42
Immunocytochemical localization of the precursor protein for beta-amyloid in the rat central nervous system. Neuron (1988) 1.40
Topically administered acyclovir in the treatment of recurrent herpes simplex genitalis: a controlled trial. J Infect Dis (1983) 1.21
In vivo gene modification elucidates subtype-specific functions of alpha(2)-adrenergic receptors. J Pharmacol Exp Ther (2000) 1.18
Effect of denaturation on the susceptibility of proteins to enzymic phosphorylation. J Biol Chem (1975) 1.17
Co-localization of corticotropin releasing factor and vasopressin mRNA in neurones after adrenalectomy. Nature (1985) 1.17
Detection of proopiomelanocortin mRNA by in situ hybridization with an oligonucleotide probe. Proc Natl Acad Sci U S A (1986) 1.16
Identification and characterization of alpha 2D-adrenergic receptors in bovine pineal gland. Mol Pharmacol (1991) 1.15
Characterization of alpha-2 adrenergic receptors in the OK cell, an opossum kidney cell line. J Pharmacol Exp Ther (1988) 1.14
Pharmacological characterizations of adrenergic receptors in human adipocytes. J Clin Invest (1981) 1.06
Alpha-2A is the predominant alpha-2 adrenergic receptor subtype in human spinal cord. Anesthesiology (1992) 1.06
Alpha-2 adrenergic receptor subtypes indicated by [3H]yohimbine binding in human brain. Life Sci (1986) 1.06
Decomposition of phosphoserine and phosphothreonine during acid hydrolysis. Anal Biochem (1976) 1.05
Characterization of the alpha-2C adrenergic receptor subtype in the opossum kidney and in the OK cell line. J Pharmacol Exp Ther (1991) 1.04
Prolonged continuous versus intermittent oral acyclovir treatment in normal adults with frequently recurring genital herpes simplex virus infection. Am J Med (1988) 1.04
(+/-)-[3H]Epinephrine and (-)[3H]dihydroalprenolol binding to beta1- and beta2-noradrenergic receptors in brain, heart, and lung membranes. J Biol Chem (1978) 1.04
Alpha-2 adrenergic receptor development in rat CNS: an autoradiographic study. Neuroscience (2004) 1.02
Forskolin does not activate sperm adenylate cyclase. Mol Pharmacol (1983) 1.00
Development of the norepinephrine transporter in the rat CNS. Neuroscience (2005) 1.00
Differential effects of neonatal norepinephrine lesions on immediate early gene expression in developing and adult rat brain. Neuroscience (2008) 0.99
Characterization of [3H]yohimbine binding to putative alpha-2 adrenergic receptors in neonatal rat lung. J Pharmacol Exp Ther (1982) 0.98
Characterization and possible mechanisms of alpha 2-adrenergic receptor-mediated sensitization of forskolin-stimulated cyclic AMP production in HT29 cells. J Biol Chem (1988) 0.98
Characterization of alpha 1- and alpha 2-adrenergic receptors. Int Rev Neurobiol (1983) 0.98
alpha 2-Adrenergic receptors appear in rat salivary glands after reserpine treatment. Nature (1980) 0.97
Proteolytic processing of beta-amyloid precursor by calpain I. J Neurosci (1990) 0.97
Postsynaptic localization of alpha 2-adrenergic receptors in rat submandibular gland. J Neurosci (1981) 0.96
A double-blind, placebo-controlled study of oral acyclovir in postherpetic neuralgia. Psychosomatics (1990) 0.96
Characterization of [3H]RX821002 binding to alpha-2 adrenergic receptor subtypes. J Pharmacol Exp Ther (1994) 0.95
Solubilization and characterization of putative alpha-2 adrenergic isoceptors from the human platelet and the rat cerebral cortex. J Pharmacol Exp Ther (1985) 0.95
Platelet MAO and measures of attention and impulsivity in boys with attention deficit disorder and hyperactivity. Psychiatry Res (1986) 0.95
Baseline exploratory activity predicts anxiolytic responsiveness to diazepam in five mouse strains. Brain Res Bull (1982) 0.94
A fragment of vasoactive intestinal peptide, VIP(10-28), is an antagonist of VIP in the colon carcinoma cell line, HT29. Peptides (1987) 0.94
alpha 2-Adrenergic receptor binding in human platelets: alterations during the menstrual cycle. Clin Pharmacol Ther (1983) 0.94
Alpha-2 adrenergic regulation of norepinephrine release in the rat submandibular gland as measured by HPLC-EC. Life Sci (1984) 0.94
Identification of phosphoglycoproteins obtained from rat brain. FEBS Lett (1976) 0.93
Identification of an endogenous peptide-ligand for the benzodiazepine receptor. Biochem Biophys Res Commun (1980) 0.93
31P nuclear magnetic resonance studies on the phosphoglycopeptides obtained from rat brain glycoprotein. FEBS Lett (1976) 0.93
Progressive secretory dysfunction in the rat submandibular gland after excretory duct ligation. Arch Oral Biol (1982) 0.93
Double-blind, placebo-controlled trial comparing long-term suppressive with short-term oral acyclovir therapy for management of recurrent genital herpes. Am J Med (1988) 0.93
Oral acyclovir for treatment of first-episode herpes simplex virus proctitis. JAMA (1988) 0.93
Acyclovir prevents reactivation of herpes simplex labialis in skiers. JAMA (1988) 0.93
Independent variation of beta-adrenergic receptor binding and catecholamine-stimulated adenylate cyclase activity in rat erythrocytes. Life Sci (1976) 0.92
Biochemical analysis of isolated bullfrog sarcolemma. Biochim Biophys Acta (1966) 0.91
The prevalence of attention deficit disorders in a rural midwestern community sample of nine-year-old children. J Am Acad Child Psychiatry (1985) 0.91
Current perspectives on childhood depression: an overview. Am J Psychiatry (1981) 0.90
Characterization of serotonin-1B receptors negatively coupled to adenylate cyclase in OK cells, a renal epithelial cell line from the opossum. J Pharmacol Exp Ther (1989) 0.89
In situ hybridization of putative somatostatin mRNA within hypothalamus of the rat using synthetic oligonucleotide probes. J Cell Biochem (1985) 0.89
Characterization of a cDNA encoding rat sterol carrier protein2. DNA Cell Biol (1990) 0.89
Juvenile metachromatic leucodystrophy. Case report with clinical, histopathological, ultrastructural and biochemical observations. Acta Neuropathol (1973) 0.89
Glucocorticoid sensitivity of vasopressin mRNA levels in the paraventricular nucleus of the rat. Proc Natl Acad Sci U S A (1986) 0.89
Alpha 2-adrenergic receptor stimulation of phospholipase A2 and of adenylate cyclase in transfected Chinese hamster ovary cells is mediated by different mechanisms. Mol Pharmacol (1991) 0.89
Pharmacokinetics and tolerance of desciclovir, a prodrug of acyclovir, in healthy human volunteers. Antimicrob Agents Chemother (1987) 0.89
Alpha 2-adrenergic receptors in the human cell line, HT29. Characterization with the full agonist radioligand [3H]UK-14,304 and inhibition of adenylate cyclase. Mol Pharmacol (1985) 0.88
Alpha 2-adrenergic receptor-mediated sensitization of forskolin-stimulated cyclic AMP production. Proc Natl Acad Sci U S A (1987) 0.88
Possible involvement of alpha-2A adrenergic receptors in attention deficit hyperactivity disorder: radioligand binding and polymorphism studies. Am J Med Genet B Neuropsychiatr Genet (2006) 0.88
Alterations of brain neurotransmitter receptor binding in Huntington's chorea. Brain Res (1976) 0.87
An ongoing validation of a Tier I screening battery for detecting endocrine-active compounds (EACs). Toxicol Sci (1998) 0.87
A DNA polymorphism of an apoprotein gene associates with the hypertriglyceridaemia of primary gout. Hum Genet (1988) 0.87
Species orthologs of the alpha-2A adrenergic receptor: the pharmacological properties of the bovine and rat receptors differ from the human and porcine receptors. J Pharmacol Exp Ther (1994) 0.87
Identification in rodents and other species of an mRNA homologous to the human beta-amyloid precursor. Brain Res (1988) 0.87
Agonist-stimulated [35S]GTPgammaS autoradiography: optimization for high sensitivity. Eur J Pharmacol (2001) 0.87
Studies on desensitization of adrenergic receptors of human adipocytes. Metabolism (1982) 0.87
Detection of the environmental antiandrogen p,p-DDE in CD and long-evans rats using a tier I screening battery and a Hershberger assay. Toxicol Sci (1999) 0.86
Amitriptyline in children with major depressive disorder: a double-blind crossover pilot study. J Am Acad Child Psychiatry (1984) 0.86
Molecular determinants of the alpha-2D adrenergic receptor subtype. Life Sci (1993) 0.86
Regulation of autonomic receptors in rat submandibular gland. Mol Pharmacol (1982) 0.86
Buffers differentially alter the binding of [3H]rauwolscine and [3H]RX821002 to the alpha-2 adrenergic receptor subtypes. J Pharmacol Exp Ther (1996) 0.85
cAMP-dependent reduction in membrane fluxes during relaxation of arterial smooth muscle. Am J Physiol (1984) 0.84
Comparative effects of forskolin and isoproterenol on the cyclic AMP content of human adipocytes. Life Sci (1987) 0.84
Mechanism of down-regulation of alpha-2 adrenergic receptor subtypes. J Pharmacol Exp Ther (1997) 0.84
Alpha-2 adrenergic receptor functional coupling to G proteins in rat brain during postnatal development. J Pharmacol Exp Ther (1999) 0.83
Expression of alpha 2-adrenergic receptor genes in rat tissues. Receptor (1994) 0.83
Differential localization of alpha 2-adrenergic receptor subtypes in brain. Pharmacol Biochem Behav (1992) 0.83
Influenza vaccine and dermatomyositis. Vaccine (1994) 0.83
Evaluation of a Tier I screening battery for detecting endocrine-active compounds (EACs) using the positive controls testosterone, coumestrol, progesterone, and RU486. Toxicol Sci (2000) 0.83
Desensitization of the alpha-2 adrenergic receptor in HT29 and opossum kidney cell lines. J Pharmacol Exp Ther (1990) 0.83
Inverse agonism at alpha(2)-adrenoceptors in native tissue. Eur J Pharmacol (2000) 0.82
Alpha 2A- and alpha 2C-adrenoceptor subtypes are differentially down-regulated by norepinephrine. Eur J Pharmacol (1991) 0.82
The cloning and expression of an OK cell cDNA encoding a 5-hydroxytryptamine1B receptor. Mol Pharmacol (1994) 0.82
Implementing drug education in schools: an analysis of the costs and teacher perceptions. J Sch Health (1988) 0.82
Comparison of alpha-2 adrenergic receptors and their regulation in rodent and porcine species. J Pharmacol Exp Ther (1984) 0.82
Risk-taking in the lives of parasuicides (attempted suicides). Br J Psychiatry (1971) 0.82
Do only the healthy intend to participate in worksite health promotion? Health Educ Q (1988) 0.81
Tuberculosis following therapy with infliximab may be refractory to antibiotic therapy. Rheumatology (Oxford) (2003) 0.81
Effects of chronic reserpine administration on beta adrenergic receptors, adenylate cyclase and phosphodiesterase of the rat submandibular gland. J Pharmacol Exp Ther (1981) 0.81
Interactions of neuroleptic metabolites with dopaminergic, alpha adrenergic and muscarinic cholinergic receptors. J Pharmacol Exp Ther (1981) 0.81